Literature DB >> 9875929

The prognostic importance of the ossific nucleus in the treatment of congenital dysplasia of the hip.

S J Luhmann1, P L Schoenecker, A M Anderson, G S Bassett.   

Abstract

Ischemic necrosis of the femoral head occurring after the treatment of congenital dysplasia of the hip can negatively affect the long-term prognosis of the involved hip. Some investigators have suggested that the presence of the ossific nucleus of the femoral head at the time of closed or open reduction is associated with a lower rate of ischemic necrosis. This finding, if verified, could lead to a delay in the treatment of a dislocated hip until ossification of the femoral head has begun, which may be well after the age when the patient has started to walk. We conducted a computerized search of the medical records at our two tertiary-care children's hospitals to identify all patients with congenital dysplasia of the hip who had had a closed or open reduction between January 1, 1979, and December 31, 1993. One hundred and twenty-four patients (153 hips) who satisfied the criteria for inclusion were identified. The ossific nucleus was present in ninety hips and absent in sixty-three. Closed reduction was used in 112 hips and open reduction, in forty-one. Ischemic necrosis was identified in five hips (3 percent): four (6 percent) of the sixty-three hips that did not have an ossific nucleus and one (1 percent) of the ninety hips that had an ossific nucleus at the time of the reduction. With the numbers available for study, we could not detect a difference between these two groups. The age at reduction (p > 0.99), the method of reduction (p = 0.611), previous treatment with a Pavlik harness (p = 0.592), the use of preliminary traction (p = 0.602), concomitant procedures (p > 0.99), and a failure of the primary closed reduction (p = 0.579) were not associated with the development of ischemic necrosis after reduction. In our analysis of patients who were managed over a fifteen-year period, the data did not support the hypothesis that the presence of an ossific nucleus at the time of reduction of a congenitally dislocated hip is associated with a lower prevalence of ischemic necrosis of the femoral head. Sound operative principles dictate that operative reduction of a congenitally displaced hip should be performed when the child can be safely placed under anesthesia and without regard to the presence or absence of the ossific nucleus.

Entities:  

Mesh:

Year:  1998        PMID: 9875929     DOI: 10.2106/00004623-199812000-00001

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  22 in total

Review 1.  Is Age or Surgical Approach Associated With Osteonecrosis in Patients With Developmental Dysplasia of the Hip? A Meta-analysis.

Authors:  Eduardo N Novais; Mary K Hill; Patrick M Carry; Patricia C Heyn
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

2.  Developmental Dislocation of the Hip Successfully Treated by Preoperative Traction and Medial Open Reduction: A 22-year Mean Followup.

Authors:  P Farsetti; R Caterini; V Potenza; E Ippolito
Journal:  Clin Orthop Relat Res       Date:  2015-04-01       Impact factor: 4.176

3.  Comparison of Pediatric and General Orthopedic Surgeons' Approaches in Management of Developmental Dysplasia of the Hip and Flexible Flatfoot: the Road to Clinical Consensus.

Authors:  Ramin Haj Zargarbashi; Hirbod Nasiri Bonaki; Shayan Abdollah Zadegan; Taghi Baghdadi; Mohammad Hossein Nabian; Mehdi Ramezan Shirazi
Journal:  Arch Bone Jt Surg       Date:  2017-01

4.  Osteonecrosis and femoro-acetabular impingement: sequelae of developmental dysplasia of the hip.

Authors:  Jason Pui Yin Cheung; Wang Chow; Michael To
Journal:  BMJ Case Rep       Date:  2012-03-20

5.  Does open reduction of the developmental dislocated hip increase the risk of osteonecrosis?

Authors:  Renata Pospischill; Julia Weninger; Rudolf Ganger; Johannes Altenhuber; Franz Grill
Journal:  Clin Orthop Relat Res       Date:  2011-06-04       Impact factor: 4.176

Review 6.  Developmental dysplasia of the hip: What has changed in the last 20 years?

Authors:  Pavel Kotlarsky; Reuben Haber; Victor Bialik; Mark Eidelman
Journal:  World J Orthop       Date:  2015-12-18

7.  The presence of an ossific nucleus does not protect against osteonecrosis after treatment of developmental dysplasia of the hip.

Authors:  Andreas Roposch; Odeh Odeh; Andrea S Doria; John H Wedge
Journal:  Clin Orthop Relat Res       Date:  2011-02-11       Impact factor: 4.176

8.  Does Perfusion MRI After Closed Reduction of Developmental Dysplasia of the Hip Reduce the Incidence of Avascular Necrosis?

Authors:  Alex L Gornitzky; Andrew G Georgiadis; Mark A Seeley; B David Horn; Wudbhav N Sankar
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

9.  Correlation between avascular necrosis and the presence of the ossific nucleus when treating developmental dysplasia of the hip.

Authors:  Sabit Sllamniku; Cen Bytyqi; Ardiana Murtezani; Emir Q Haxhija
Journal:  J Child Orthop       Date:  2013-10-22       Impact factor: 1.548

10.  Natural history of type III growth disturbance after treatment of developmental dislocation of the hip.

Authors:  Claudio A Fernandez; Lori A Dolan; Stuart L Weinstein; Jose A Morcuende
Journal:  Iowa Orthop J       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.